Wiley exceeds FY24 earnings guidance; FY25 outlook signals growth with GenAI momentum

JOHN WILEY & SONS, INC.

2024-FY EPS reported -$3.65 revenue$1,872,987,000

FY24 reported Adj EBITDA of $369M (guidance exceeded), Adj EPS $2.78 (vs prior $2.78? actually -19% YoY but above guidance). Adj Revenue $1,617M, within higher end of range.
FY25 outlook: Adj Revenue $1,650-1,690M, Adj EBITDA $385-410M, Adj EPS $3.25-3.60, FCF ~$125M.
GenAI content rights project completed Q4 with large tech company worth $23M; another executed project to be realized in FY25.
Value Creation Plan: 2 of 3 non-core divestitures closed; $90M of $130M run-rate cost savings actioned; net debt-to-EBITDA 1.7x.
Q4 adjusted results: Revenue +4% CC to $441M, Adj EBITDA +7% CC to $125M, Adj EPS +2% CC to $1.21.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.